ATLANTA--(BUSINESS WIRE)--Biospace med announced today that data from a clinical study of its FDA-cleared ‘EOS’ 3D x-ray orthopedic imaging system conducted by a Montreal-based hospital—“EOS: A New Breed of X-Ray Imager Using Low-Dose Slot-Scanning to Achieve High-Quality Images”—showed that the EOS ultra-low-dose orthopedic imaging system makes possible “better image quality” than CR (Computed Radiography) imaging while using nearly 10 times less radiation.”